{"transactions":[{"id":728642,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:12.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279723/ownership.xml","form_type":"4"}},{"id":728641,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:12.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279723/ownership.xml","form_type":"4"}},{"id":930940,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T13:00:04.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":15257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022."}],"balance_after":15257,"derivative":{"exercise_price":4.73,"expiration_date":"2036-01-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":15257},"source":{"system":"sec-edgar","filing":"0001193125-26-021725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526021725/ownership.xml","form_type":"4"}},{"id":1102383,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:03.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":164800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six (36) equal monthly installments following June 20, 2025 such that the option is fully vested on June 20, 2028."}],"balance_after":164800,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":164800},"source":{"system":"sec-edgar","filing":"0000950170-25-089603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089603/ownership.xml","form_type":"4"}},{"id":1304102,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T13:00:03.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":150602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date."}],"balance_after":150602,"derivative":{"exercise_price":6.07,"expiration_date":"2035-01-09","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":150602},"source":{"system":"sec-edgar","filing":"0000950170-25-004571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025004571/ownership.xml","form_type":"4"}},{"id":1489332,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T00:00:04.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":163663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024."}],"balance_after":163663,"derivative":{"exercise_price":8.15,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":163663},"source":{"system":"sec-edgar","filing":"0000950170-24-069550","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017024069550/ownership.xml","form_type":"4"}},{"id":1660522,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-03T01:00:12.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":189680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date."}],"balance_after":189680,"derivative":{"exercise_price":5.9,"expiration_date":"2034-01-31","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":189680},"source":{"system":"sec-edgar","filing":"0001493152-24-004814","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224004814/ownership.xml","form_type":"4"}},{"id":1982799,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-01T21:05:30.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023."}],"balance_after":165000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001493152-23-006392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223006392/ownership.xml","form_type":"4"}},{"id":2065263,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:32.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000227/ownership.xml","form_type":"4"}},{"id":2065262,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:32.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000227/ownership.xml","form_type":"4"}}]}